A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Recruiting now · Phase 2
Conditions studied: Proteinuric Kidney Disease
In brief
The purpose of this study is to evaluate the safety, tolerability, and effect on Albuminuria of MZE829 in Adults with APOL1 Kidney Disease.
Key facts
- Study ID
- NCT06830629
- Run by
- Maze Therapeutics
- People needed
- 74
- Starts
- 2025-02-05
- Expected to finish
- 2026-09-01
- Last updated by the study team
- 2026-07-27
Who can join
Age: 18 and older, up to 68. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Huntsville, Alabama, United States (enrolling)
- Research Site — Montgomery, Alabama, United States (enrolling)
- Research Site — Montgomery, Alabama, United States (enrolling)
- Research Site — Bloomfield, Connecticut, United States (enrolling)
- Research Site — Washington D.C., District of Columbia, United States (enrolling)
- Research Site — Atlantis, Florida, United States (enrolling)
- Research Site — Brandon, Florida, United States (enrolling)
- Research Site — Hollywood, Florida, United States (enrolling)
- Research Site — Melbourne, Florida, United States (enrolling)
- Research Site — Orlando, Florida, United States (enrolling)
- Research Site — Atlanta, Georgia, United States (enrolling)
- Research Site — College Park, Georgia, United States (enrolling)
- Research Site — Cordele, Georgia, United States (enrolling)
- Research Site — Macon, Georgia, United States (enrolling)
- Research Site — Riverdale, Georgia, United States (enrolling)
- Research Site — Riverdale, Georgia, United States (enrolling)
- Research Site — Savannah, Georgia, United States (enrolling)
- Research Site — Snellville, Georgia, United States (enrolling)
- Research Site — Chicago, Illinois, United States (enrolling)
- Research Site — Chicago, Illinois, United States (enrolling)
- Research Site — Evanston, Illinois, United States (enrolling)
- Research Site — Kansas City, Kansas, United States (enrolling)
- Research Site — Bowling Green, Kentucky, United States (enrolling)
- Research Site — Louisville, Kentucky, United States (enrolling)
- Research Site — Decatur, Alabama, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.